CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,234 | -27.3% | 2,511 | -2.0% | 0.09% | -23.8% |
| Q2 2023 | $348,150 | +27.1% | 2,562 | -2.9% | 0.12% | +23.2% |
| Q1 2023 | $273,983 | -23.1% | 2,638 | -34.3% | 0.10% | -27.2% |
| Q4 2022 | $356,156 | -23.9% | 4,018 | -31.2% | 0.14% | -33.7% |
| Q3 2022 | $468,000 | -17.6% | 5,841 | -1.6% | 0.20% | -10.9% |
| Q2 2022 | $568,000 | -33.9% | 5,933 | +2.6% | 0.23% | -24.8% |
| Q1 2022 | $859,000 | +9.8% | 5,780 | +4.8% | 0.31% | +15.5% |
| Q4 2021 | $782,000 | +12.5% | 5,514 | +3.8% | 0.26% | -16.7% |
| Q3 2021 | $695,000 | -4.7% | 5,313 | +0.2% | 0.32% | -1.9% |
| Q2 2021 | $729,000 | -2.3% | 5,305 | -7.1% | 0.32% | -5.8% |
| Q1 2021 | $746,000 | +18.8% | 5,713 | +1.8% | 0.34% | +8.9% |
| Q4 2020 | $628,000 | – | 5,611 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 217,204 | $29,850,000 | 3.08% |
| Ranger Investment Management | 260,524 | $35,804,000 | 1.87% |
| EARNEST PARTNERS LLC | 1,628,848 | $223,853,000 | 1.32% |
| Penn Capital Management Company, LLC | 87,232 | $11,988,000 | 1.16% |
| DeepCurrents Investment Group LLC | 257,334 | $35,365,000 | 1.06% |
| Champlain Investment Partners, LLC | 1,475,989 | $202,845,000 | 0.96% |
| Hood River Capital Management LLC | 224,050 | $30,791,000 | 0.92% |
| OAK RIDGE INVESTMENTS LLC | 74,178 | $10,194,000 | 0.89% |
| MOODY ALDRICH PARTNERS LLC | 45,667 | $6,276,000 | 0.88% |
| WAFRA INC. | 138,542 | $19,040,000 | 0.72% |